Microvascular Density And Vascular Endothelial Growth Factor Immunoreactivity as Predictors of Regional Lymph Node Metastasis From Betel-Associated Oral Squamous Cell Carcinoma

Journal of Oral and Maxillofacial Surgery

Volumn 61, Issue 11, 2003, Pages 1257-1262

  Wong, Yong Kie ^a,b   Liu, Chung Ji ^c   Kwan, Po Cheung ^a   Chao, Shou Yee ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; MITOGENIC AGENT; VASCULOTROPIN;

ADULT; AGE; AGED; ARTICLE; BETEL NUT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALE; MASTICATION; MICROVASCULATURE; MOUTH CARCINOMA; MOUTH HYGIENE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0242349600     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-2391(03)00725-0     Document Type: Article

References (25)

1. Kerbel RS: Tumor angiogenesis: Past, present and the near future. Carcinogenesis 21:505, 2000
2. Weidner N: Tumoural vascularity as prognostic factor in cancer patients: The evidence continues to grow. J Pathol 184:119, 1998
3. Sauter ER, Nesbit M, Watson JC, et al: Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res 5:775, 1999
4. Tae K, El-Naggar AK, Yoo E, et al: Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis. Clin Cancer Res 6:2821, 2000
5. Smith BD, Smith GL, Carter D, et al: Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18:2046, 2000
6. Artese L, Rubini C, Ferrero G, et al: Microvessel density (MVD) and vascular endothelial growth factor expression (VEGF) in human oral squamous cell carcinoma. Anticancer Res 21:689, 2001
7. Den Hart B, Guidi A, Tognazzi K, et al: Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia. Lab Invest 77:659, 1997
8. Mineta H, Miura K, Ogino T, et al: Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 83:775, 2000
9. Maeda T, Matsumura S, Hiranuma H, et al: Expression of vascular endothelial growth factor in human oral squamous cell carcinoma: Its association with tumour progression and p53 gene status. J Clin Pathol 51:771, 1998
10. Moriyama M, Kumagai S, Kawashiri S, et al: Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 33:369, 1997
11. Gleich L, Biddinger P, Pavelic Z: Tumor angiogenesis in T1 oral cavity squamous cell carcinoma: Role in predicting tumor aggressiveness. Head Neck 18:343, 1996
12. Carlile J, Harada K, Baillie R, et al: Vascular endothelial growth factor (VEGF) expression in oral tissues: Possible relevance to angiogenesis, tumour progression and field cancerisation. J Oral Pathol Med 30:449, 2001
13. Pazouki S, Chisholm M, Abi MM, et al: The association between tumor progression and vascularity in the oral mucosa. J Pathol 183:39, 1998
14. Penfold CN, Partridge M, Rojas R, et al: The role of angiogenesis in the spread of oral squamous cell carcinoma. Br J Oral Maxillofac Surg 34:37, 1996
15. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 333:1757, 1996
16. O'Reilly M, Boehm T, Shing Y, et al: Endostatin, an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277, 1997
17. Boehm T, Folkman J, Browder T, et al: Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nat Med 390:404, 1997
18. St Croix B, Rago C, Velculescu V, et al: Genes expressed in human tumor endothelium. Science 289:1197, 2000
19. Carson-Walter EB, Watkins DN, Nanda A, et al: Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 61:6649, 2001
20. Keck P, Hauser S, Krivi G, et al: Vascular permeability factor, an endothelial cell mitogen related to platelet derived growth factor. Science 246:1309, 1989
21. Ferrara N: Vascular endothelial growth factor. Eur J Cancer 32:2413, 1996
22. Dvorak H, Brown L, Detmar M, et al: Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029, 1995
23. Wong YK, Liu TY, Chang KW, et al: p53 alterations in betel quid- and tobacco-associated oral squamous cell carcinomas from Taiwan. J Oral Pathol Med 27:243, 1998
24. Chang KW, Lin SC, Kwan PC, et al: Association of aberrant p53 and p21(WAF1) immunoreactivity with the outcome of oral verrucous leukoplakia in Taiwan. J Oral Pathol Med 29:56, 2000
25. Parums D, Cordell J, Micklem K: JC70A: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol 43:752, 1990